GIRGENTI STEVEN (Executive Chairman) received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 7/6/2023ACC: 0001493152-23-023821
DirectorOfficer· Executive Chairman
Since Aug 2022
+28.39K
Net shares
Net buyer
$56.3K
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
28.39K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+8.23K
Price / share
$2.28
Trade value
$18.76K
% of position
1.0%
1/1/2023
861.10K→869.33K
Common Stock
Direct
Shares
+9.92K
Price / share
$1.89
Trade value
$18.75K
% of position
1.1%
4/15/2023
869.33K→879.25K
Common Stock
Direct
Shares
+10.24K
Price / share
$1.83
Trade value
$18.75K
% of position
1.2%
7/1/2023
879.25K→889.49K
Total
Net shares
+28.39K
Net value
$56.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2023 | A · Award | +8.23K | $2.28 | $18.76K | 1.0% | 861.10K | 869.33K |
| Common Stock Direct | 4/15/2023 | A · Award | +9.92K | $1.89 | $18.75K | 1.1% | 869.33K | 879.25K |
| Common Stock Direct | 7/1/2023 | A · Award | +10.24K | $1.83 | $18.75K | 1.2% | 879.25K | 889.49K |
| Total | +28.39K | $56.25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned8.96K
Total
8.96K indirect8.96K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.96K | Indirect |
| Total | 8.96K | 8.96K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported